This patent covers a method of administering a hematopoeitic stem cell activatory factor into a host using a depot-like formulation. One of the problems of protien administration into humans is that many proteins have a short half live and therefore the pharmacokinetic profiles may not be adequate for stimulation of the biological response needed. This patent seems to overcome this problem.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.